Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Move over, oncology: Obesity, diabetes meds will take over 2030's top drug rankings, Evaluate forecasts
Fierce Pharma
Fri, 07/12/24 - 11:33 am
Tags:
obesity, diabetes, oncology, Novo Nordisk, Eli Lilly
Patients on weight-loss drugs should inform doctor before surgery, EU regulator says
Reuters
Fri, 07/12/24 - 11:16 am
Tags:
EMA, Novo Nordisk, Ozempic, Wegovy, Eli Lilly, Mounjaro, Zepbound, surgery
Lilly’s Mounjaro Helps Patients Lose More Weight Than Novo’s Ozempic: Study
BioSpace
Tue, 07/9/24 - 11:51 am
Tags:
Eli Lilly, Mounjaro, Novo Nordisk, Ozempic, weight loss
FDA approval is just the beginning. Now Lilly’s Kisunla faces the tough Alzheimer’s market
Pharma Voice
Tue, 07/9/24 - 11:24 am
Tags:
Eli Lilly, Kisunla, Alzheimer's disease
Myricx Bio Raises $115M in Series A to Advance ADC With Lilly and Novo Backing
BioSpace
Mon, 07/8/24 - 11:01 pm
Tags:
Myricx Bio, funding, antibody-drug conjugate, Eli Lilly
Lilly inks $3.2B Morphic buyout to snag oral rival to Takeda's IBD blockbuster
Fierce Biotech
Mon, 07/8/24 - 11:54 am
Tags:
Eli Lilly, Morphic, M&A, Takeda, Entyvio, IBD
GLP-1s May Cut Risk of 10 Obesity-Related Cancers in Diabetes Patients: Study
BioSpace
Mon, 07/8/24 - 11:49 am
Tags:
GLP-1, Ozempic, Novo Nordisk, Eli Lilly, obesity, cancer
Eli Lilly Alzheimer's drug approved by US FDA
Reuters
Tue, 07/2/24 - 03:09 pm
Tags:
Eli Lilly, donanemab, Alzheimer's disease, FDA, Kisunla
Biden joins Sanders' campaign targeting Novo Nordisk, Eli Lilly's diabetes and obesity drug prices
Fierce Pharma
Tue, 07/2/24 - 11:46 am
Tags:
Joe Biden, Bernie Sanders, Novo Nordisk, Eli Lilly, drug pricing, diabetes, weight loss
India panel urges drug regulator to approve Lilly's obesity drug Mounjaro
Reuters
Mon, 07/1/24 - 09:52 pm
Tags:
Eli Lilly, Mounjaro, India, obesity
Radionetics Oncology Enters Into Strategic Agreement With Lilly
Businesswire
Mon, 07/1/24 - 11:16 am
Tags:
Eli Lilly, Radionetics Oncology, radiopharmaceuticals, M&A
Don’t call it a comeback: Biotech’s CNS resurgence forges Big Pharma connections
Pharma Voice
Fri, 06/28/24 - 11:17 am
Tags:
Big Pharma, Neuroscience, Prothena Biosciences, Biogen, Eisai, Pfizer, AbbVie, Eli Lilly, Bristol Myers Squibb
Where the future of Alzheimer's drugs is heading
Axios
Fri, 06/28/24 - 11:15 am
Tags:
Alzheimer's disease, drug development, Eli Lilly
House panel proposes new strategy for Medicare to cover weight loss drugs Wegovy, Zepbound
Stat
Thu, 06/27/24 - 11:13 am
Tags:
Novo Nordisk, Medicare, Wegovy, Zepbound, Eli Lilly, legislation
Eli Lilly inks OpenAI deal for discovering new antibiotics
Fierce Biotech
Tue, 06/25/24 - 11:28 am
Tags:
Eli Lilly, OpenAI, antimicrobial resistance, antibiotics
5 FDA Decisions to Watch in the Second Half of 2024
BioSpace
Mon, 06/24/24 - 11:29 am
Tags:
FDA, Eli Lilly, donanemab, Alzheimer's disease, Adaptimmune, afami-cel, advanced synovial sarcoma, Lykos Therapeutics, MDMA, PTSD, Bristol Myers Squibb, KarXT, schizophrenia, Daiichi Sankyo, AstraZeneca, Dato-DXd, non-small cell lung cancer
Lilly Sees Path for Zepbound’s Label Expansion With Phase III Sleep Apnea Win
BioSpace
Mon, 06/24/24 - 11:20 am
Tags:
Eli Lilly, Zepbound, clinical trials, sleep apnea
What Would a Donanemab Approval Mean for Leqembi?
BioSpace
Mon, 06/24/24 - 10:47 am
Tags:
Eli Lilly, donanemab, Biogen, Eisai, Leqembi, FDA, Alzheimer's disease
Lilly files more lawsuits to curb sales of counterfeit Mounjaro
Reuters
Thu, 06/20/24 - 11:26 am
Tags:
Eli Lilly, drug counterfeiting, Mounjaro
Eli Lilly Scores Another Major Win and Lines Up Its Next Blockbuster
Motley Fool
Sun, 06/16/24 - 08:54 pm
Tags:
Eli Lilly, Alzheimer's disease, donanemab

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.